PMC Endorses Democratic and Republican Positions on Personalized Medicine
News Sep 16, 2008
The Personalized Medicine coalition has applauded statements issued by both the Republican and Democratic presidential campaigns endorsing the principles of personalized medicine and its role in improving healthcare.
The Republican platform on health care encourages physicians "to personalize and coordinate their care to ensure [that patients] receive the right treatment with the right doctor at the right time."
In its "plan to combat cancer," building upon Senator Obama's Genomics and Personalized Medicine Act, the Obama-Biden campaign issued a statement on September 2, 2008, which pledged "to support advances in personalized medicine to help ensure early detection and treatment of cancer and other diseases."
The PMC expresses support for these statements, and the bipartisan commitment they represent to advance the development and adoption of personalized medicine.
The PMC has worked both with Senator Obama on crafting his bill to advance personalized medicine and with Secretary Leavitt on his personalized health care initiative at the Department of Health and Human Services.
"We are pleased that both parties recognize the important role of medical innovation, and in particular the value of personalized medicine, in helping us address our healthcare challenges, including improving health and containing total healthcare costs," said Edward Abrahams, Executive Director of the Personalized Medicine Coalition.
The Personalized Medicine Coalition said that it looks forward to working with both parties on healthcare policies that support the development and adoption of personalized medicine, and is pleased that while other issues may divide the candidates, their commitment to progress through innovation in personalized medicine unites them.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE